Lihegen

Lihegen is a Shanghai-based biotechnology company that specializes in the development and commercialization of molecular diagnostic solutions. The company focuses on point-of-care testing (POCT) and high-throughput molecular diagnostic platforms, providing a comprehensive suite of products including automated nucleic acid extraction systems and real-time PCR instruments. Lihegen's diagnostic portfolio covers a wide range of clinical needs, including infectious disease detection, oncology, and reproductive health. By integrating advanced molecular biology techniques with automated engineering, the company aims to provide rapid, accurate, and user-friendly diagnostic tools for clinical and research settings. Lihegen was incubated by the Lihe Group, leveraging strong academic and industrial ties to drive innovation in the in vitro diagnostics (IVD) sector.